Serum sodium level, mmol/L | No. of patients/deaths | Model 1 a | Model 2 b | ||
---|---|---|---|---|---|
HR (95% CIs) | P value | HR (95% CIs) | P value | ||
90-Day all-cause mortality | |||||
Fitted groups | |||||
< 136.0 | 3678/1066 | 1.68 (1.55, 1.81) | < 0.001 | 1.38 (1.27, 1.50) | < 0.001 |
136.0–144.9 | 9161/1827 | 1.00 | 1.00 | ||
≥ 145.0 | 782/261 | 1.76 (1.54, 2.01) | < 0.001 | 1.56 (1.36, 1.79) | < 0.001 |
Quintiles | |||||
< 135.0 | 2910/880 | 2.00 (1.81, 2.20) | < 0.001 | 1.57 (1.41, 1.75) | < 0.001 |
135.0–138.9 | 4193/902 | 1.22 (1.10, 1.35) | < 0.001 | 1.16 (1.04, 1.28) | 0.005 |
139.0–141.9 | 3914/722 | 1.00 | 1.00 | ||
142.0–145.9 | 2063/459 | 1.25 (1.11, 1.40) | < 0.001 | 1.24 (1.10, 1.40) | < 0.001 |
≥ 146.0 | 541/191 | 2.05 (1.74, 2.41) | < 0.001 | 1.75 (1.48, 2.07) | < 0.001 |
30-Day all-cause mortality | |||||
Fitted groups | |||||
< 136.0 | 3678/747 | 1.70 (1.55, 1.86) | < 0.001 | 1.37 (1.24, 1.51) | < 0.001 |
136.0–144.9 | 9161/1226 | 1.00 | 1.00 | ||
≥ 145.0 | 782/184 | 1.79 (1.53, 2.10) | < 0.001 | 1.51 (1.28, 1.78) | < 0.001 |
Quintiles | |||||
< 135.0 | 2910/618 | 2.03 (1.80, 2.29) | < 0.001 | 1.55 (1.36, 1.77) | < 0.001 |
135.0–138.9 | 4193/623 | 1.25 (1.11, 1.41) | < 0.001 | 1.18 (1.05, 1.34) | 0.008 |
139.0–141.9 | 3914/479 | 1.00 | 1.00 | ||
142.0–145.9 | 2063/300 | 1.22 (1.05, 1.41) | 0.008 | 1.20 (1.03, 1.39) | 0.018 |
≥ 146.0 | 541/137 | 2.12 (1.75, 2.58) | < 0.001 | 1.68 (1.37, 2.05) | < 0.001 |